Cancer
SCRI has a broad experience in the fast growing therapeutic field of haematology and oncology
Tan, T.J., Ang, W.X.G., Wang, WW. Et al. A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma. Nat Commun 13, 6453 (2022). https://doi.org/10.1038/s41467-022-33834-4
